Laurent Arnaud, Ronald van Vollenhoven
Advanced Handbook of Systemic Lupus Erythematosus (eBook, PDF)
52,95 €
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
26 °P sammeln
52,95 €
Als Download kaufen
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
26 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
26 °P sammeln
Laurent Arnaud, Ronald van Vollenhoven
Advanced Handbook of Systemic Lupus Erythematosus (eBook, PDF)
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Provides an advanced overview of the latest evidence-based current and emerging treatment recommendations Written and edited by leading experts within the field of rheumatology and systemic lupus erythematosus research Includes major international guidelines such as EULAR and ACR recommendations among others
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 11.47MB
Andere Kunden interessierten sich auch für
Outcome Measures and Metrics in Systemic Lupus Erythematosus (eBook, PDF)72,95 €
Systemic Lupus Erythematosus (eBook, PDF)72,95 €
Lupus Erythematosus (eBook, PDF)160,95 €
Pathogenesis of Systemic Lupus Erythematosus (eBook, PDF)80,95 €
Systemic Lupus Erythematosus (eBook, PDF)72,95 €
Ronald van VollenhovenBiologics for the Treatment of Rheumatoid Arthritis (eBook, PDF)40,95 €
Meningitis and Encephalitis (eBook, PDF)72,95 €-
-
-
Provides an advanced overview of the latest evidence-based current and emerging treatment recommendations
Includes major international guidelines such as EULAR and ACR recommendations among others
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Springer International Publishing
- Seitenzahl: 167
- Erscheinungstermin: 10. September 2017
- Englisch
- ISBN-13: 9783319430355
- Artikelnr.: 52933559
- Verlag: Springer International Publishing
- Seitenzahl: 167
- Erscheinungstermin: 10. September 2017
- Englisch
- ISBN-13: 9783319430355
- Artikelnr.: 52933559
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Professor Ronald F van Vollenhoven is Chief of the Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID) at the Karolinska Institute, and of the Clinical Trials Unit Rheumatology at the Karolinska University Hospital. He received his MD and PhD degrees from the University of Leiden in The Netherlands. After graduating in 1984 he pursued immunology research at Cornell Medical College in New York, followed by a residency (specialty training) in internal medicine at the State University of New York at Stony Brook, and a fellowship in rheumatology at Stanford University in Palo Alto following which he received American Board of Internal Medicine certification in both internal medicine and rheumatology. From 1993 to 1998 Professor van Vollenhoven held a faculty appointment as Assistant Professor of Medicine in the Division of Immunology and Rheumatology at Stanford University, and from 1995 he was the Medical Services Chief and Fellowship Director in that division. In 1998 Professor van Vollenhoven moved to Stockholm, Sweden, where he worked as a Senior Physician and Chief of the Clinical Trials Unit in the Department of Rheumatology at the Karolinska University Hospital and Associate Professor of Rheumatology; and in 2010, he was appointed in his current position as Professor and Unit Chief at the Karolinska Institute. Professor van Vollenhoven's research interests focus around the development and systematic evaluation of biologic and immunomodulatory treatments for the rheumatic diseases. With his co-workers, he has established the Stockholm registry for biological therapies (the STURE database) for this purpose, which has supported research projects relating to clinical efficacy, pharmacology, outcomes, and pharmacoeconomics. He has been principal investigator in many clinical trials of novel therapies in rheumatic diseases and has contributed to a number of important investigator-initiated trials including the SWEFOT trial. He has published over 300 original papers, book chapters and reviews, and is Editor of the textbook Targeted Treatment of the Rheumatic Diseases and associate-editor of Dubois' Lupus Erythematosus. In 2004, Professor van Vollenhoven was awarded the Scandinavian Research Foundation Prize for excellence in clinical research in rheumatology, and he is an honorary member of several rheumatology societies. He is the Editor-in-Chief of Lupus Science & Medicine, Chair of the EULAR Standing Committee on Clinical Affairs, member of many editorial boards, past-chair of the Swedish Rheumatology Society Professors' Council, co-founder of the IRBIS registry for biologics in systemic lupus erythematosus (SLE), the CERERRA registries collaboration, and the NORD-STAR collaboration for Nordic trials in the rheumatic diseases, and the initiator of the Treat-to-Target-in-SLE initiative. Professor van Vollenhoven lives just north of Stockholm with his wife and children aged 22 and 18. Outside his professional life he is an avid classical pianist.
Introduction.- Disease classification.- Disease manifestation.- Diagnosis.- Treatments.- Therapies in late-stage clinical development.- Specific issues.- Outcome, prognosis, and perspectives.
Introduction.- Disease classification.- Disease manifestation.- Diagnosis.- Treatments.- Therapies in late-stage clinical development.- Specific issues.- Outcome, prognosis, and perspectives.







